English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Technology/Innovation

+ Technology/Innovation
Amanda Rupp | May 12, 2016

FDA broadens Imbruvica label for CLL, SLL patients

+ Technology/Innovation
Amanda Rupp | May 11, 2016

Lower risk of death, amputation exists for PAD patients taking statins

+ Community
Amanda Rupp | May 11, 2016

AHA praises Nestle's efforts to promote healthier, low-sodium products

+ Technology/Innovation
Amanda Rupp | May 11, 2016

AMA releases new online resources for physicians

+ Regulatory
Jamie Barrand | May 11, 2016

Lawmakers leery of new CMS rule

+ Community
Amanda Rupp | May 11, 2016

BioMarin releases EMA grants for Batten disease treatment

+ Technology/Innovation
Amanda Rupp | May 11, 2016

Restoring blood flow to PAD patients’ legs shows promising benefits

+ Regulatory
Kim Sunderland | May 10, 2016

Florida congressman urges reversion to pre-ACA health care system

Trending

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

  • « First
  • «
  • …
  • 457
  • 458
  • 459
  • 460
  • 461
  • 462
  • 463
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily